Plain-English translation of NCT07086443 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing several types of placental tissue patches—called allografts—to see if they help diabetic foot ulcers heal better when used alongside your regular wound care. Researchers will compare people who receive one of these patches plus standard care to a matched control group over 12 weeks. The goal is to find out whether this new treatment closes nonhealing diabetic foot ulcers more effectively than standard care alone.
Many people with diabetes develop foot ulcers that don't heal well with standard care alone, which can lead to serious complications. This study exists to determine whether using placental tissue patches as part of wound treatment can help these stubborn ulcers close faster and more reliably.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of several types of placental tissue patches plus standard wound care, or to receive standard care alone. You will need to attend weekly study visits for 12 weeks, during which your ulcer will be measured and assessed for healing. You must also keep your foot properly offloaded (rested and protected) using the method prescribed by the study team throughout the trial.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States